United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 1,448,800 | 1,627,800 | 1,725,300 | 1,598,800 | 1,465,800 |
| Cost of Goods | 117,600 | 198,700 | 105,700 | 72,700 | 69,000 |
| Gross Profit | 1,331,200 | 1,429,100 | 1,619,600 | 1,526,100 | 1,396,800 |
| Operating Expenses | 1,519,400 | 624,400 | 805,400 | 465,100 | 697,800 |
| Operating Income | -187,600 | 805,400 | 814,900 | 1,061,700 | 699,000 |
| Interest Expense | 44,200 | 13,900 | 9,000 | 3,900 | 4,700 |
| Other Income | 66,800 | -32,600 | -36,400 | 2,400 | 350,100 |
| Pre-tax Income | -165,000 | 758,900 | 769,500 | 1,060,200 | 1,044,400 |
| Income Tax | -60,500 | 169,700 | 351,600 | 346,500 | 392,800 |
| Net Income Continuous | -104,500 | 589,200 | 417,900 | 713,700 | 651,600 |
| Net Income | $-104,500 | $589,200 | $417,900 | $713,700 | $651,600 |
| EPS Basic Total Ops | -2.39 | 13.54 | 9.50 | 16.29 | 14.17 |
| EPS Basic Continuous Ops | -2.39 | 13.54 | 9.50 | 16.29 | 14.17 |
| EPS Diluted Total Ops | -2.39 | 13.39 | 9.31 | 15.25 | 12.72 |
| EPS Diluted Continuous Ops | -2.39 | 13.39 | 9.31 | 15.25 | 12.73 |
| EPS Diluted Before Non-Recurring Items | -2.39 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-141,700 | $841,300 | $845,900 | $1,093,300 | $731,900 |